1. Home
  2. BIOX vs RFL Comparison

BIOX vs RFL Comparison

Compare BIOX & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioceres Crop Solutions Corp.

BIOX

Bioceres Crop Solutions Corp.

N/A

Current Price

$0.53

Market Cap

61.5M

Sector

Industrials

ML Signal

N/A

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

N/A

Current Price

$1.50

Market Cap

61.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BIOX
RFL
Founded
2001
2017
Country
Argentina
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Real Estate
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
61.5M
61.1M
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
BIOX
RFL
Price
$0.53
$1.50
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$4.33
N/A
AVG Volume (30 Days)
497.2K
89.3K
Earning Date
01-01-0001
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.28
EPS
N/A
N/A
Revenue
N/A
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$37.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.96
52 Week Low
$0.40
$1.12
52 Week High
$5.35
$3.19

Technical Indicators

Market Signals
Indicator
BIOX
RFL
Relative Strength Index (RSI) 36.19 72.54
Support Level $0.53 $1.41
Resistance Level $0.67 $1.64
Average True Range (ATR) 0.06 0.10
MACD 0.02 0.02
Stochastic Oscillator 53.63 75.00

Price Performance

Historical Comparison
BIOX
RFL

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: